ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

ClinicalTrials.gov ID: NCT05399888

Public ClinicalTrials.gov record NCT05399888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 7:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Dementia

Study identification

NCT ID
NCT05399888
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biogen
Industry
Enrollment
416 participants

Conditions and interventions

Interventions

  • BIIB080 Drug
  • BIIB080-matching placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 23, 2022
Primary completion
May 13, 2026
Completion
Jan 7, 2029
Last update posted
May 17, 2025

2022 – 2029

United States locations

U.S. sites
36
U.S. states
13
U.S. cities
33
Facility City State ZIP Site status
Xenoscience Inc. Phoenix Arizona 85004
HonorHealth Neurology Scottsdale Arizona 85251
Banner Sun Health Research Institute Sun City Arizona 85351
Center for Neurosciences Tucson Arizona 85718
Mary S. Easton Center for Alzheimer's Disease Research, UCLA Los Angeles California 90095
PNS Clinical Research, LLC dba Orange California 92868
Stanford Hospital and Clinics Palo Alto California 94304
Sutter Institute for Medical Research Sacramento California 95816
University of California San Diego Medical Center San Diego California 92103
University of California San Francisco (PARENT) San Francisco California 94143
Rocky Mountain Movement Disorders Center, PC Englewood Colorado 80113
Charter Research, LLC Lady Lake Florida 32159
K2 Medical Research, LLC Orlando Florida 32751
Advent Health Orlando Florida 32804
Conquest Research Winter Park Florida 32789
Charter Research, LLC Winter Park Florida 32792
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
Brigham and Women's Hospital Department of Neurology Boston Massachusetts 02115-5804
Beth Israel Deaconess Medical Center Boston Massachusetts 02216
Lahey Clinic Medical Center - Burlington Burlington Massachusetts 01805
Boston Center for Memory Newton Massachusetts 02459
Neurological Associates of Albany, PC Albany New York 12208
Dent Neurologic Institute Amherst New York 14226
New York University Medical Center PRIME New York New York 10016
South Shore Neurologic Associates, P.C. Patchogue New York 11772
SUNY Upstate Medical University Syracuse New York 13210
Duke University Durham North Carolina 27710
AMC Research, LLC Matthews North Carolina 28105
NeuroScience Research Center, LLC. Canton Ohio 44718
University of Cincinnati Physicians Group, LLC Cincinnati Ohio 45206-0829
Butler Hospital Providence Rhode Island 02906
Neurology Clinic, PC Cordova Tennessee 38018
Neurology Consultants of Dallas, PA Dallas Texas 75243
University of Texas Health Science Center at San Antonio San Antonio Texas 78229
EvergreenHealth Kirkland Washington 98034
Kingfisher Cooperative, LLC Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05399888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2025 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05399888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →